Batch of GSK's hepatitis B vaccine recalled over ineffectiveness
This article was originally published in Scrip
Executive Summary
Nearly 10,000 doses of GlaxoSmithKline's hepatitis B vaccine Engerix have been deemed ineffective by the UK's regulatory agency, the MHRA, resulting in a class 2 product recall.